rs77595156

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001042432.2(CLN3):​c.1211A>G​(p.His404Arg) variant causes a missense change. The variant allele was found at a frequency of 0.0549 in 1,613,844 control chromosomes in the GnomAD database, including 5,394 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. H404N) has been classified as Benign.

Frequency

Genomes: 𝑓 0.11 ( 1778 hom., cov: 33)
Exomes 𝑓: 0.049 ( 3616 hom. )

Consequence

CLN3
NM_001042432.2 missense

Scores

12
6

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:13

Conservation

PhyloP100: 4.04

Publications

18 publications found
Variant links:
Genes affected
CLN3 (HGNC:2074): (CLN3 lysosomal/endosomal transmembrane protein, battenin) This gene encodes a protein that is involved in lysosomal function. Mutations in this, as well as other neuronal ceroid-lipofuscinosis (CLN) genes, cause neurodegenerative diseases commonly known as Batten disease or collectively known as neuronal ceroid lipofuscinoses (NCLs). Many alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2008]
CLN3 Gene-Disease associations (from GenCC):
  • inherited retinal dystrophy
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • neuronal ceroid lipofuscinosis
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • neuronal ceroid lipofuscinosis 3
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Myriad Women's Health

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001042432.2, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0019387603).
BP6
Variant 16-28477622-T-C is Benign according to our data. Variant chr16-28477622-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 128776.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.272 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001042432.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CLN3
NM_001042432.2
MANE Select
c.1211A>Gp.His404Arg
missense
Exon 16 of 16NP_001035897.1Q13286-1
CLN3
NM_000086.2
c.1211A>Gp.His404Arg
missense
Exon 15 of 15NP_000077.1Q13286-1
CLN3
NM_001286104.2
c.1139A>Gp.His380Arg
missense
Exon 15 of 15NP_001273033.1Q13286-7

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CLN3
ENST00000636147.2
TSL:1 MANE Select
c.1211A>Gp.His404Arg
missense
Exon 16 of 16ENSP00000490105.1Q13286-1
CLN3
ENST00000359984.12
TSL:1
c.1211A>Gp.His404Arg
missense
Exon 15 of 15ENSP00000353073.9Q13286-1
CLN3
ENST00000565316.6
TSL:1
c.1160A>Gp.His387Arg
missense
Exon 14 of 14ENSP00000456117.1Q13286-3

Frequencies

GnomAD3 genomes
AF:
0.113
AC:
17161
AN:
152020
Hom.:
1771
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.276
Gnomad AMI
AF:
0.0263
Gnomad AMR
AF:
0.0631
Gnomad ASJ
AF:
0.0363
Gnomad EAS
AF:
0.123
Gnomad SAS
AF:
0.159
Gnomad FIN
AF:
0.0730
Gnomad MID
AF:
0.0253
Gnomad NFE
AF:
0.0333
Gnomad OTH
AF:
0.0858
GnomAD2 exomes
AF:
0.0759
AC:
18997
AN:
250390
AF XY:
0.0749
show subpopulations
Gnomad AFR exome
AF:
0.281
Gnomad AMR exome
AF:
0.0389
Gnomad ASJ exome
AF:
0.0364
Gnomad EAS exome
AF:
0.128
Gnomad FIN exome
AF:
0.0719
Gnomad NFE exome
AF:
0.0337
Gnomad OTH exome
AF:
0.0471
GnomAD4 exome
AF:
0.0488
AC:
71386
AN:
1461706
Hom.:
3616
Cov.:
31
AF XY:
0.0513
AC XY:
37282
AN XY:
727134
show subpopulations
African (AFR)
AF:
0.283
AC:
9491
AN:
33480
American (AMR)
AF:
0.0404
AC:
1809
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0364
AC:
951
AN:
26136
East Asian (EAS)
AF:
0.0987
AC:
3918
AN:
39700
South Asian (SAS)
AF:
0.155
AC:
13346
AN:
86256
European-Finnish (FIN)
AF:
0.0655
AC:
3489
AN:
53240
Middle Eastern (MID)
AF:
0.0444
AC:
256
AN:
5766
European-Non Finnish (NFE)
AF:
0.0311
AC:
34588
AN:
1112008
Other (OTH)
AF:
0.0586
AC:
3538
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
4396
8792
13188
17584
21980
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1558
3116
4674
6232
7790
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.113
AC:
17205
AN:
152138
Hom.:
1778
Cov.:
33
AF XY:
0.116
AC XY:
8625
AN XY:
74368
show subpopulations
African (AFR)
AF:
0.276
AC:
11461
AN:
41482
American (AMR)
AF:
0.0629
AC:
962
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.0363
AC:
126
AN:
3472
East Asian (EAS)
AF:
0.123
AC:
637
AN:
5168
South Asian (SAS)
AF:
0.159
AC:
768
AN:
4828
European-Finnish (FIN)
AF:
0.0730
AC:
774
AN:
10600
Middle Eastern (MID)
AF:
0.0272
AC:
8
AN:
294
European-Non Finnish (NFE)
AF:
0.0332
AC:
2260
AN:
67984
Other (OTH)
AF:
0.0878
AC:
185
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
713
1426
2140
2853
3566
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
182
364
546
728
910
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0542
Hom.:
1972
Bravo
AF:
0.115
Asia WGS
AF:
0.132
AC:
456
AN:
3478
EpiCase
AF:
0.0318
EpiControl
AF:
0.0290

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
6
not specified (6)
-
-
2
Neuronal ceroid lipofuscinosis 3 (2)
-
-
2
not provided (2)
-
-
1
Inborn genetic diseases (1)
-
-
1
Neuronal ceroid lipofuscinosis (1)
-
-
1
Neuronal Ceroid-Lipofuscinosis, Dominant/Recessive (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.25
T
BayesDel_noAF
Uncertain
0.010
CADD
Uncertain
25
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.77
D
Eigen
Uncertain
0.47
Eigen_PC
Uncertain
0.47
FATHMM_MKL
Uncertain
0.90
D
LIST_S2
Uncertain
0.90
D
MetaRNN
Benign
0.0019
T
MetaSVM
Benign
-1.3
T
MutationAssessor
Uncertain
2.0
M
PhyloP100
4.0
PrimateAI
Uncertain
0.52
T
PROVEAN
Uncertain
-2.9
D
REVEL
Uncertain
0.57
Sift
Benign
0.55
T
Sift4G
Benign
0.12
T
Varity_R
0.42
gMVP
0.54
Mutation Taster
=94/6
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs77595156;
hg19: chr16-28488943;
COSMIC: COSV61107434;
COSMIC: COSV61107434;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.